NCT03668639 - Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

March 1, 2023

Study Completion Date

April 15, 2023

Conditions

Chemotherapy-induced Nausea and VomitingAdverse EventCervical Cancer

Interventions

DRUG

Akynzeo

Weekly administration of akynzeo for five weeks.

DRUG

Dexamethasone

Weekly administration of dexamethasone 12 mg Day 1, 8 mg Day 2-3, and 4 mg Day 4 for five weeks.

Trial Locations (1)

RECRUITING

Department of Oncology, Odense University Hospital, Odense